Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00250
Species: Homo sapiens
Position : chr1:47677466-47678021
Year: 2023
Title: TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: acute myeloid leukemia
PMID:  36632736
MONDO: MONDO:0018874
Tissue: Bone Marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: GDM-1
CVCL ID: CVCL_1230
Cell Type: myeloid leukemia cell
Cell Ontology ID: CL:0001054
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, ChIP-RT-qPCR, RT-RT-qPCR, Western blot
About Target Gene
Target gene : TAL1
About TF
TF name : MYB
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MYB AP-1 transcription factor network pid 71
MYB C-MYB transcription factor network pid 87
MYB Factors involved in megakaryocyte development and platelet production reactome 111
MYB IL2 signaling events mediated by PI3K pid 38
MYB IL4-mediated signaling events pid 66
MYB Notch-mediated HES/HEY network pid 48
MYB Prolactin netpath 105
MYB Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00247 chr1:47677466-47678021 Blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00248 chr1:47677466-47678021 Blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00249 chr1:47677466-47678021 Blood patient-derived xenograft cell T-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer